Gerald Edelman advises Allvida on MedTech group acquisition

Gerald Edelman has advised Allvida Group AB (Allvida) on the acquisition of MMS Medical Limited (MMS), which became official on 12 December 2025.

MMS is one of Ireland’s leading medical equipment suppliers and is the largest supplier in the Republic of Ireland. It specialises in mobility, rehabilitation, and disabled access and community care products.

Gerald Edelman’s team included Matt Ball, Liam Wallace, Hayden Davies Busby, and Lucy Douglas. They acted as the buy-side financial due diligence adviser, supporting Allvida during the transaction.

Allvida, which partners with “leading and niched” MedTech companies, was founded by Systematic Growth, a Swedish firm operating globally who acquire entrepreneur-led companies. 

Matt Ball, director at Gerald Edelman, said: “We are pleased to have supported Willem and the Allvida team on the successful completion of this acquisition, further strengthening our Corporate Finance team’s track record in the healthcare sector.”

Willem Roest, head of M&A at Allvida, added: “It was great working with the GE team. They are knowledgeable, always available and pragmatic and just nice people to work with.”